Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.3195
-0.0262 (-7.58%)
At close: Oct 6, 2026, 4:00 PM EDT
0.3183
-0.0012 (-0.38%)
After-hours: Oct 6, 2026, 5:03 PM EDT
Cosmos Health Revenue
Cosmos Health had revenue of $18.99M in the quarter ending June 30, 2026, with 28.76% growth. This brings the company's revenue in the last twelve months to $73.73M, up 33.82% year-over-year. In the year 2025, Cosmos Health had annual revenue of $65.27M with 19.93% growth.
Revenue (ttm)
$73.73M
Revenue Growth
+33.82%
P/S Ratio
0.44
Revenue / Employee
$452,318
Employees
163
Market Cap
32.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.27M | 10.85M | 19.93% |
| Dec 31, 2024 | 54.43M | 1.05M | 1.97% |
| Dec 31, 2023 | 53.38M | 3.03M | 6.02% |
| Dec 31, 2022 | 50.35M | -5.89M | -10.48% |
| Dec 31, 2021 | 56.24M | 833.33K | 1.50% |
| Dec 31, 2020 | 55.41M | 15.73M | 39.65% |
| Dec 31, 2019 | 39.68M | 2.59M | 6.99% |
| Dec 31, 2018 | 37.08M | 7.07M | 23.56% |
| Dec 31, 2017 | 30.01M | 23.26M | 344.28% |
| Dec 31, 2016 | 6.76M | 6.22M | 1,165.53% |
| Dec 31, 2015 | 533.80K | -7.11M | -93.01% |
| Dec 31, 2014 | 7.64M | 6.74M | 746.55% |
| Dec 31, 2013 | 902.37K | - | - |
| Dec 31, 2012 | - | - | - |
| Jul 31, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 410.98B |
| Cencora | 332.77B |
| Cardinal Health | 254.25B |
| Henry Schein | 13.60B |
| Accendra Health | 2.65B |
| 111, Inc. | 1.54B |
| EDAP TMS | 79.31M |
| Akso Health Group | 13.83M |
COSM News
- 5 days ago - Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion - Accesswire
- 7 days ago - Cosmos Health’s CosmoFarm reaches annualized revenue above $60M - TheFly
- 7 days ago - Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - Accesswire
- 8 days ago - Cosmos’ contract manufacturing division surpasses $20M in implied revenue - TheFly
- 8 days ago - Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline - Accesswire
- 21 days ago - Cosmos Health secures five-year contract manufacturing agreement - TheFly
- 21 days ago - Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June - Accesswire
- 22 days ago - Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market - Accesswire